A prospective real-world analysis of intravenous eptinezumab in migraine management: the first UK experience
Abstract Background Clinical trials have shown the safety and statistical superiority of intravenous eptinezumab to placebo in migraine prevention in adults. However, data in real-world settings is sparse. Methods This is a prospective open-label single centre real-world analysis aiming to establish...
Tallennettuna:
| Päätekijät: | , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2025-10-01
|
| Sarja: | The Journal of Headache and Pain |
| Aiheet: | |
| Linkit: | https://doi.org/10.1186/s10194-025-02180-3 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|